Sichenzia Ross Ference Carmel LLP Represents Sharps Technology, Inc. in $5.6 Million Registered Direct Offering and Concurrent Private Placement 

Press Release – New York, NY – October 2, 2023 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sharps Technology, Inc. (“The Company”) (NASDAQ: “STSS” and “STSSW”) an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, in a registered direct offering with institutional investors. The Company issued 4,418,521 shares of common stock and pre-funded warrants to acquire common stock in a registered direct offering. The purchase price of each share was $0.64. The purchase price for the pre-funded warrants was identical to the purchase price for shares, less the exercise price of $0.001 per share.

In a concurrent private placement, the Company also issued to the same investors units to purchase pre-funded warrants to purchase up to 2,581,479 shares of common stock and common warrants to purchase 8,750,000 shares of common stock at an exercise price of $0.64 per share. Aggregate gross proceeds to the Company of both transactions were approximately $5.6 million.

The Sichenzia Ross Ference Carmel LLP team was led by partners Arthur Marcus, and associates Matthew Siracusa and Jesse Blue.